Inflammation in COPD: implications for management.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  American Journal of Medicine

• Publication date

  2012-12-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1016/j.amjmed.2012.06.024PMID 23164484
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Persisting remodeling and less airway wall eosinophil activation in complete remission of asthma.

  2011cited by this paper
• TNF-alpha inhibitors in asthma and COPD: we must not throw the baby out with the bath water.

  2010cited by this paper
• Inhaled Corticosteroids in COPD: A Controversy

  2010cited by this paper
• Long-acting anticholinergic use in chronic obstructive pulmonary disease: efficacy and safety

  2010cited by this paper
• Mechanisms of corticosteroid resistance in severe asthma and chronic obstructive pulmonary disease (COPD).

  2010cited by this paper
• Treatment effects of low-dose theophylline combined with an inhaled corticosteroid in COPD.

  2010cited by this paper
• New Therapies for Chronic Obstructive Pulmonary Disease

  2010cited by this paper
• Impact of exacerbations on COPD

  2010cited by this paper
• Deaths: preliminary data for 2008.

  2010cited by this paper
• Metabolic syndrome associated with increased risk of acute exacerbation of COPD: a preliminary study

  2010cited by this paper
• Remodeling in asthma and COPD – differences and similarities

  2010cited by this paper
• Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents

  2010cited by this paper
• Metabolic Syndrome is associated with increased risk of acute exacerbation of COPD: a preliminary study

  2010cited by this paper
• Budesonide and formoterol inhibit inflammatory mediator production by bronchial epithelial cells infected with rhinovirus

  2009cited by this paper
• Prevalence of pulmonary embolism in acute exacerbations of COPD: a systematic review and metaanalysis.

  2009cited by this paper
• Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials.

  2009cited by this paper
• Effects of formoterol and salmeterol on cytokine release from monocyte-derived macrophages

  2009cited by this paper
• Low-dose theophylline enhances the anti-inflammatory effects of steroids during exacerbations of COPD

  2009cited by this paper
• The pathology of chronic obstructive pulmonary disease.

  2009cited by this paper
• Tiotropium bromide exerts anti-inflammatory activity in a cigarette smoke mouse model of COPD.

  2009cited by this paper
• Anti-inflammatory effects of salmeterol/fluticasone, tiotropium/fluticasone or tiotropium in COPD

  2009cited by this paper
• Change in inflammation in out-patient COPD patients from stable phase to a subsequent exacerbation

  2009cited by this paper
• Progression of chronic obstructive pulmonary disease: impact of inflammation, comorbidities and therapeutic intervention.

  2009cited by this paper
• Effect of fluticasone with and without salmeterol on pulmonary outcomes in chronic obstructive pulmonary disease: a randomized trial.

  2009cited by this paper
• Knowledge and attitudes of family physicians coming to COPD continuing medical education

  2008cited by this paper
• Increased systemic inflammation is a risk factor for COPD exacerbations.

  2008cited by this paper
• Suppressive activity of tiotropium bromide on matrix metalloproteinase production from lung fibroblasts in vitro

  2008cited by this paper
• Acetylcholine mediates the release of IL-8 in human bronchial epithelial cells by a NFkB/ERK-dependent mechanism.

  2008cited by this paper
• TNF-alpha antagonists and the prevention of hospitalisation for chronic obstructive pulmonary disease.

  2008cited by this paper
• Global strategy for asthma management and prevention: GINA executive summary

  2008cited by this paper
• Inflammatory profile of new bacterial strain exacerbations of chronic obstructive pulmonary disease.

  2008cited by this paper
• Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study.

  2008cited by this paper
• Immunology of asthma and chronic obstructive pulmonary disease

  2008influential reference
• TNF-α antagonists and the prevention of hospitalisation for chronic obstructive pulmonary disease ☆

  2008cited by this paper
• Airways inflammation and treatment during acute exacerbations of COPD

  2008cited by this paper
• Salmeterol with fluticasone enhances the suppression of IL-8 release and increases the translocation of glucocorticoid receptor by human neutrophils stimulated with cigarette smoke

  2008cited by this paper
• Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis.

  2008cited by this paper
• Emerging pharmacotherapies for COPD.

  2008cited by this paper
• Acetylcholine-induced proliferation of fibroblasts and myofibroblasts in vitro is inhibited by tiotropium bromide.

  2007cited by this paper
• Effect of salmeterol/fluticasone propionate on airway inflammation in COPD: a randomised controlled trial

  2007cited by this paper
• Anti-inflammatory activity of β2-agonists in primary lung epithelial cells is independent of glucocorticoid receptor

  2007cited by this paper
• Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.

  2007cited by this paper
• Relationship between airway colonization, inflammation and exacerbation frequency in COPD.

  2007cited by this paper
• Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.

  2007cited by this paper
• Inflammatory changes, recovery and recurrence at COPD exacerbation

  2007cited by this paper
• Systemic cytokines, clinical and physiological changes in patients hospitalized for exacerbation of COPD.

  2007cited by this paper
• Inhaled corticosteroids for stable chronic obstructive pulmonary disease.

  2007cited by this paper
• CHRONIC OBSTRUCTIVE PULMONARY DISEASE Profiling serum biomarkers in patients with COPD: associations with clinical parameters

  2007cited by this paper
• A pooled analysis of FEV1 decline in COPD patients randomized to inhaled corticosteroids or placebo.

  2007cited by this paper
• Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.

  2007cited by this paper
• Enhancing COPD management in primary care settings.

  2007cited by this paper
• Tiotropium suppresses acetylcholine-induced release of chemotactic mediators in vitro.

  2007cited by this paper
• The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease.

  2007cited by this paper
• Antiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung disease.

  2006cited by this paper
• Effects of smoking cessation on lung function and airway inflammation in smokers with asthma.

  2006cited by this paper
• International Primary Care Respiratory Group (IPCRG) Guidelines: diagnosis of respiratory diseases in primary care.

  2006cited by this paper
• International Primary Care Respiratory Group (IPCRG) Guidelines: management of chronic obstructive pulmonary disease (COPD).

  2006cited by this paper
• Effect of Interactions Between Lower Airway Bacterial and Rhinoviral Infection in Exacerbations of COPD

  2006cited by this paper
• Pathology of chronic obstructive pulmonary disease

  2006cited by this paper
• Treating asthma as an inflammatory disease.

  2006cited by this paper
• The mechanisms, diagnosis, and management of severe asthma in adults.

  2006cited by this paper
• Inflammatory cells in the airways in COPD

  2006cited by this paper
• Asthma exacerbations · 3: Pathogenesis

  2006cited by this paper
• Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations.

  2006cited by this paper
• Roflumilast fully prevents emphysema in mice chronically exposed to cigarette smoke.

  2005cited by this paper
• Airway inflammation during stable and acutely exacerbated chronic obstructive pulmonary disease

  2005cited by this paper
• Physician and patient perceptions in COPD: the COPD Resource Network Needs Assessment Survey.

  2005cited by this paper
• MMP-9, TIMP-1 and inflammatory cells in sputum from COPD patients during exacerbation

  2005cited by this paper
• Decreased histone deacetylase activity in chronic obstructive pulmonary disease.

  2005cited by this paper
• The nature of small-airway obstruction in chronic obstructive pulmonary disease.

  2004cited by this paper
• Soluble Interleukin-5 Receptor Alpha Is Increased in Acute Exacerbation of Chronic Obstructive Pulmonary Disease

  2004cited by this paper
• Pathophysiology of airflow limitation in chronic obstructive pulmonary disease.

  2004cited by this paper
• Efficacy and safety of a monoclonal antibody recognizing interleukin-8 in COPD: a pilot study.

  2004cited by this paper
• The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation

  2004cited by this paper
• Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper.

  2004cited by this paper
• Possible anti-inflammatory effect of salmeterol against interleukin-8 and neutrophil activation in asthma in vivo

  2003cited by this paper
• Inhaled corticosteroids reduce the progression of airflow limitation in chronic obstructive pulmonary disease: a meta-analysis

  2003cited by this paper
• Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease.

  2003cited by this paper
• Chronic obstructive pulmonary disease: molecular and cellularmechanisms

  2003cited by this paper
• Eosinophilic Bronchitis

  2003cited by this paper
• The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind, placebo-controlled biopsy study.

  2002cited by this paper
• Smoking and airway inflammation in patients with mild asthma.

  2001cited by this paper
• Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial

  2000cited by this paper
• The relationship between airways inflammation and asthma severity.

  2000cited by this paper
• Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations

  2000cited by this paper
• Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease.

  1999cited by this paper
• Neutrophilic inflammation in severe persistent asthma.

  1999cited by this paper
• Long-Term Treatment with Inhaled Budesonide in Persons with Mild Chronic Obstructive Pulmonary Disease Who Continue Smoking

  1999cited by this paper
• Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease.

  1999cited by this paper
• Salmeterol reduces early- and late-phase plasma leakage and leukocyte adhesion in rat airways.

  1997cited by this paper
• Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD.

  1997cited by this paper
• Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study.

  1997cited by this paper
• Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T lymphocytes with FEV1.

  1997cited by this paper
• Inhibitory effect of salmeterol on the respiratory burst of adherent human neutrophils

  1996cited by this paper
• Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma.

  1996cited by this paper
• Intraluminal airway inflammation in chronic bronchitis. Characterization and correlation with clinical parameters.

  1989cited by this paper

• Stability studies of glycopyrronium bromide and in vitro toxicity evaluation of its major transformation products by LC-MS/MS and NMR

  2025cites this paper
• Integrated Bioinformatic Analyses Constructed a Novel Immune Escape‐Related Signature and Classifier to Predict Tuberculosis

  2025cites this paper
• Asthma and COPD Beyond the Airways: Exploring Neurocognitive Links Through NF-κB Subunits c-Rel and p65

  2025cites this paper
• Nanocurcumin modulates Th17 cell responses in moderate and severe COPD patients

  2024cites this paper
• Gut virome alterations in patients with chronic obstructive pulmonary disease

  2024cites this paper
• Role of Corticosteroids in Treatment of Chronic Obstructive Pulmonary Disease (COPD)

  2024cites this paper
• Potential association between obstructive lung diseases and cognitive decline

  2024cites this paper
• Effectiveness of Guided Imagery to %FEV1, Absolut Neutrophil, Anxiety, and Quality of Life in Stable Chronic Obstructive Pulmonary Disease (COPD) Patient

  2024cites this paper
• Impact of smoking on gut microbiota and short-chain fatty acids in human and mice: Implications for COPD.

  2024cites this paper
• Inflammatory Markers and Fatigue in Individuals With Moderate to Severe Chronic Obstructive Pulmonary Disease

  2024influential citation
• Exploring the Potential Role of Metabolomics in COPD: A Concise Review

  2024cites this paper
• Long-term exposure to air pollution and risk of Sarcopenia in adult residents of Taiwan: a nationwide retrospective cohort study

  2023cites this paper
• Potential of hydroethanolic leaf extract of Ocimum sanctum in ameliorating redox status and lung injury in COPD: an in vivo and in silico study

  2023cites this paper
• Omega-3 Polyunsaturated Fatty Acids in Managing Comorbid Mood Disorders in Chronic Obstructive Pulmonary Disease (COPD): A Review

  2023cites this paper
• Systemic inflammation mediates environmental polycyclic aromatic hydrocarbons to increase chronic obstructive pulmonary disease risk in United States adults: a cross-sectional NHANES study

  2023cites this paper
• Particulate matter-induced metabolic recoding of epigenetics in macrophages drives pathogenesis of chronic obstructive pulmonary disease.

  2023cites this paper
• The serious health consequences of abuse and neglect in early life

  2023cites this paper
• IL-26 in the Lung and Its Role in COPD Inflammation

  2022cites this paper
• Prognostic value of post-discharge depression in patients recently hospitalized with acute heart failure

  2022cites this paper
• Sarcopenia is associated with cardiovascular risk in men with COPD, independent of adiposity

  2022cites this paper
• Sympathetic and Vagal Nerve Activity in COPD: Pathophysiology, Presumed Determinants and Underappreciated Therapeutic Potential

  2022cites this paper
• The Roles of Blood Lipid-Metabolism Genes in Immune Infiltration Could Promote the Development of IDD

  2022cites this paper
• Capillary instability of a two-layer annular film: an airway closure model

  2022cites this paper
• Taxifolin ameliorates cigarette smoke-induced chronic obstructive pulmonary disease via inhibiting inflammation and apoptosis.

  2022cites this paper
• Effects of Tai Chi on patients with moderate to severe COPD in stable phase

  2022cites this paper
• Overview of herbal therapy of acute and chronic pulmonary disease: a conceptual map

  2022cites this paper
• Systemic inflammation induced by exacerbation of COPD or pneumonia in patients with COPD induces cardiac troponin elevation

  2021cites this paper
• Surface‐bound matrix metalloproteinase‐8 on macrophages: Contributions to macrophage pericellular proteolysis and migration through tissue barriers

  2021cites this paper
• Comparative effects of capsaicin in chronic obstructive pulmonary disease and asthma (Review)

  2021cites this paper
• Aberrant Post-Transcriptional Regulation of Protein Expression in the Development of Chronic Obstructive Pulmonary Disease

  2021cites this paper
• Syk-Targeted, a New 3-Arylbenzofuran Derivative EAPP-2 Blocks Airway Inflammation of Asthma–COPD Overlap in vivo and in vitro

  2021cites this paper
• COPD_A_323616 2605..2615

  2021cites this paper
• Identification of Inflammation-Related Biomarker Lp-PLA2 for Patients With COPD by Comprehensive Analysis

  2021cites this paper
• Nucleotide-Oligomerizing Domain-1 Activation Exaggerates Cigarette Smoke-Induced Chronic Obstructive Pulmonary-Like Disease in Mice

  2021cites this paper
• Compare the Effect of Inhaled Corticosteroids and Systemic Corticosteroids on Sputum Microbiome of AECOPD

  2021cites this paper
• Screening and Identification of Hub Genes in the Corticosteroid Resistance Network in Human Airway Epithelial Cells via Microarray Analysis

  2021cites this paper
• COPD_A_271864 2727..2737

  2020cites this paper
• Highlight article: Hydrogen sulfide alleviates cigarette smoke-induced COPD through inhibition of the TGF-β1/smad pathway

  2020cites this paper
• Hyperuricemia Is Not Predictive of Long-Term Outcome in Patients with Stable Chronic Obstructive Pulmonary Disease

  2020cites this paper
• Fractional Exhaled Nitric Oxide is Associated with the Severity of Stable COPD

  2020cites this paper
• Chemerin: A Potential Regulator of Inflammation and Metabolism for Chronic Obstructive Pulmonary Disease and Pulmonary Rehabilitation

  2020cites this paper
• High cytomegalovirus serology and subsequent COPD-related mortality: a longitudinal study

  2020cites this paper
• Mechanism of YuPingFeng in the Treatment of COPD Based on Network Pharmacology

  2020cites this paper
• Effects of extracellular Hsp70, lipopolysaccharide and lipoteichoic acid on human monocyte-derived macrophages and differentiated THP-1 cells

  2020cites this paper
• Ammonia exposure causes lung injuries and disturbs pulmonary circadian clock gene network in a pig study.

  2020cites this paper
• Myrcene exerts anti-asthmatic activity in neonatal rats via modulating the matrix remodeling

  2020cites this paper
• Circulating miR-1246 in the Progression of Chronic Obstructive Pulmonary Disease (COPD) in Patients from the BODE Cohort

  2020cites this paper
• Comparison of Serum Heart-Type Fatty Acid Binding Protein Levels in Stable Chronic Obstructive Pulmonary Disease and Healthy Subjects

  2020influential citation
• The effect of low dose teophillyne on the improvement of copd assessment test score, interleukin-8 level and sputum neutrophil count in patients with stable COPD

  2019cites this paper
• Airway infection with Nontypeable Haemophilus influenzae is more rapidly eradicated in vitamin D deficient mice.

  2019cites this paper
• Noninvasive positive pressure ventilation in stable patients with COPD.

  2019cites this paper
• Improvement in inflammation and airway remodelling after acupuncture at BL13 and ST36 in a mouse model of chronic asthma

  2019cites this paper
• Metabolomic Profiling Differences among Asthma, COPD, and Healthy Subjects: A LC-MS-based Metabolomic Analysis.

  2019cites this paper
• Protective Effect of Jianpiyifei II Granule against Chronic Obstructive Pulmonary Disease via NF-κB Signaling Pathway

  2018cites this paper
• Role of Inflammatory Risk Factors in the Pathogenesis of Streptococcus pneumoniae

  2018cites this paper
• Effects of YuPingFeng granules on acute exacerbations of COPD: a randomized, placebo-controlled study

  2018cites this paper
• Serum endocan levels in patients with stable COPD

  2018cites this paper
• Sputum or blood eosinophil association with clinical measures of COPD severity in the SPIROMICS cohort

  2018cites this paper
• and blood concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort.

  2018cites this paper
• effects of YuPingFeng granules on acute exacerbations of COPD: a randomized, placebo-controlled study

  2018cites this paper
• effects of YuPingFeng granules on acute exacerbations of COPD: a randomized, placebo-controlled study

  2018cites this paper
• T-cell profile and systemic cytokine levels in overweight-obese patients with moderate to very-severe COPD.

  2018cites this paper
• Extracellular Hsp70 induces inflammation and modulates LPS/LTA-stimulated inflammatory response in THP-1 cells

  2017cites this paper
• Acute exacerbation of COPD: Diagnosis and management.

  2017cites this paper
• Metabolic changes of different high-resolution computed tomography phenotypes of COPD after budesonide–formoterol treatment

  2017cites this paper
• Sputum or blood eosinophil association with clinical measures of COPD severity in the SPIROMICS cohort

  2017cites this paper
• Resveratrol therapeutics combines both antimicrobial and immunomodulatory properties against respiratory infection by nontypeable Haemophilus influenzae

  2017cites this paper
• Glucocorticoids Regulate Tight Junction Permeability of Lung Epithelia by Modulating Claudin 8.

  2016cites this paper
• Elevated plasma cytochrome c levels in patients with chronic obstructive pulmonary disease

  2016cites this paper
• Compartmentalized signaling in the lung

  2016cites this paper
• The mechanisms and consequences of bacterial colonisation in chronic obstructive pulmonary disease

  2016cites this paper
• A-kinase anchoring proteins: Cyclic AMP compartmentalization in neurodegenerative and obstructive pulmonary diseases

  2016cites this paper
• Forced expiratory volume in one second can predict SYNTAX score in patients with chronic obstructive pulmonary disease.

  2016cites this paper
• MAP3K19 Is Overexpressed in COPD and Is a Central Mediator of Cigarette Smoke-Induced Pulmonary Inflammation and Lower Airway Destruction

  2016cites this paper
• Inhalation of ambroxol inhibits cigarette smoke-induced acute lung injury in a mouse model by inhibiting the Erk pathway.

  2016cites this paper
• Alteration of spontaneous brain activity in COPD patients

  2016cites this paper
• Gender difference in plasma fatty-acid-binding protein 4 levels in patients with chronic obstructive pulmonary disease

  2016cites this paper
• Prioritization of COPD protein biomarkers, based on a systematic study of the literature

  2016cites this paper
• Utjecaj sistemske upale na homeostazu željeza u egzacerbaciji i stabilnoj fazi kronične opstrukcijske plućne bolesti

  2016cites this paper
• Animal models for anti-emphysema drug discovery

  2015cites this paper
• Gene and Protein Expression of Fibronectin and Tenascin-C in Lung Samples from COPD Patients

  2015cites this paper
• Higher Lipoprotein (a) Levels Are Associated with Better Pulmonary Function in Community-Dwelling Older People – Data from the Berlin Aging Study II

  2015cites this paper
• Home-based pulmonary rehabilitation improves clinical features and systemic inflammation in chronic obstructive pulmonary disease patients

  2015cites this paper
• Roflumilast improves corticosteroid resistance COPD bronchial epithelial cells stimulated with toll like receptor 3 agonist

  2015cites this paper
• Effect of oral N-acetylcysteine on COPD patients with microsatellite polymorphism in the heme oxygenase-1 gene promoter

  2015cites this paper
• Prevention of acute exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline.

  2015cites this paper
• Metabolomic profiling of asthma and chronic obstructive pulmonary disease: A pilot study differentiating diseases.

  2015cites this paper
• IL-17A and the Promotion of Neutrophilia in Acute Exacerbation of Chronic Obstructive Pulmonary Disease.

  2015cites this paper
• Functional Capacity, Health Status, and Inflammatory Biomarker Profile in a Cohort of Patients With Chronic Obstructive Pulmonary Disease

  2015cites this paper
• The formulation of a pressurized metered dose inhaler containing theophylline for inhalation.

  2015cites this paper
• Facteurs pronostiques de la réadaptation respiratoire chez les patients atteints de broncho-pneumopathie chronique obstructive (BPCO)

  2015cites this paper
• Role of EPAC in axon determination

  2015cites this paper
• Airway Remodeling in Chronic Obstructive Pulmonary Disease and Asthma: the Role of Matrix Metalloproteinase-9

  2015influential citation
• Chapter 5: A-kinase anchoring proteins: Cyclic AMP compartmentalization in neurodegenerative and obstructive pulmonary diseases

  2015cites this paper
• effect of oral N -acetylcysteine on cOPD patients with microsatellite polymorphism in the heme oxygenase-1 gene promoter

  2015cites this paper
• Co morbidity of bronchial asthma and chronic obstructive pulmonary disease

  2014cites this paper
• Clinical characteristics and prognostic significance of chronic obstructive pulmonary disease in patients with atrial fibrillation: results from a multicenter atrial fibrillation registry study.

  2014cites this paper
• Respiratory Syncytial Virus Can Infect Basal Cells and Alter Human Airway Epithelial Differentiation

  2014cites this paper
• Effects and Mechanism of Bufei Yishen Formula in a Rat Chronic Obstructive Pulmonary Disease Model

  2014cites this paper
• The role of cefditoren in the treatment of lower community-acquired respiratory tract infections (LRTIs): from bacterial eradication to reduced lung inflammation and epithelial damage.

  2014cites this paper